STAT3 and cancer: On the other hand, inhibition of negative regulators such as PIAS3, SOCS1 and 3 and several cellular phosphatases (SHP1 and 2, PTPRD, PTPRT, PTPN1 and 2, DUSP22) can also lead to STAT3 activation in cancer.